Argenx SE vs Codexis, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Argenx SE is the larger company by market value: $52.8 B against $140 M for Codexis, Inc., 377 times as much (market caps of Aug 1, 2026 for Argenx SE and Oct 26, 2026 for Codexis, Inc.). Argenx SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Argenx SE had more revenue: $4.2 B against $70 M for Codexis, Inc., both in the year to December 2025.
- Argenx SE made a net profit of $1.3 B, while Codexis, Inc. made a net loss of $44 M.
- Argenx SE keeps more of each dollar of sales: a net margin of 31.1% against -62.5% for Codexis, Inc.
- Argenx SE employs more people: 1,863 against 261 at Codexis, Inc. Each employee brings in about $2,229,458 of revenue at Argenx SE and $269,693 at Codexis, Inc.
- Argenx SE's revenue grew faster in its latest fiscal year: +89.9% against +18.6% for Codexis, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Argenx SE ARGX · #477 in the world | Codexis, Inc. CDXS · #17,521 in the world |
|---|---|---|
| Profile | ||
| Country | 🇳🇱 Netherlands | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2008 | 2002 |
| Size | ||
| Market cap | $52.8 B | $140 M |
| Revenue | $4.2 B | $70 M |
| Net income | $1.3 B▲ best | $-44 M |
| Employees | 1,863 | 261 |
| Valuation | ||
| P/E ratio | 40.9× | — |
| Price to sales | 12.7× | 1.6× |
| Price to book | 7.2× | 2.8× |
| Free cash flow yield | 1.3%▲ best | -17.0% |
| Profitability | ||
| Gross margin | — | 86.7% |
| Operating margin | 25.4%▲ best | -59.3% |
| Net margin | 31.1%▲ best | -62.5% |
| Return on equity | 20.1%▲ best | -74.9% |
| Growth | ||
| Revenue growth | 89.9%▲ best | 18.6% |
| Revenue growth, 3 years a year | — | -20.2% |
| Earnings per share growth | 53.1% | — |
| Financial strength | ||
| Debt to equity | — | 0.8× |
| Cash | ||
| Free cash flow margin | 16.4%▲ best | -33.9% |
| Strength scores | ||
| Piotroski F-score | — | 4 of 9 |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Argenx SE or Codexis, Inc.?
Argenx SE is the larger company by market value: $52.8 B against $140 M for Codexis, Inc., 377 times as much (market caps of Aug 1, 2026 for Argenx SE and Oct 26, 2026 for Codexis, Inc.). Argenx SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Argenx SE or Codexis, Inc.?
Argenx SE had more revenue: $4.2 B against $70 M for Codexis, Inc., both in the year to December 2025. Argenx SE made a net profit of $1.3 B, while Codexis, Inc. made a net loss of $44 M.
Which is more profitable, Argenx SE or Codexis, Inc.?
Argenx SE keeps more of each dollar of sales: a net margin of 31.1% against -62.5% for Codexis, Inc.
Which has more employees, Argenx SE or Codexis, Inc.?
Argenx SE employs more people: 1,863 against 261 at Codexis, Inc. Each employee brings in about $2,229,458 of revenue at Argenx SE and $269,693 at Codexis, Inc.
Which is growing faster, Argenx SE or Codexis, Inc.?
Argenx SE's revenue grew faster in its latest fiscal year: +89.9% against +18.6% for Codexis, Inc.
More about Argenx SE
More about Codexis, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.